Product
CELZ-201-DDT
1 clinical trial
2 indications
Indication
Low Back PainIndication
degenerative disc diseaseClinical trial
A Double-blinded, Randomized, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability, and Effectiveness of CELZ-201-DDT Administered by Intramuscular Injection for the Treatment of Chronic Lower Back Pain in Patients With Degenerative Disc DiseaseStatus: Recruiting, Estimated PCD: 2025-05-21